Child Neurology: Migraine with aura in children

Neurology

Volumn 75, Issue 5, 2010, Pages

  Gelfand, Amy A ^a   Fullerton, Heather J ^a   Goadsby, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; CALCIUM CHANNEL BLOCKING AGENT; FLUNARIZINE; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SUMATRIPTAN; VALPROATE SEMISODIUM; VERAPAMIL;

ABDOMINAL PAIN; ADOLESCENT; BRAIN TUMOR; CASE REPORT; CROHN DISEASE; DEMYELINATING DISEASE; GASTROINTESTINAL SYMPTOM; HEMIPARESIS; HEMIPLEGIC MIGRAINE; HOSPITAL ADMISSION; HUMAN; HYPOCALCEMIA; HYPOGLYCEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIGRAINE AURA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 77955376581     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ebdd53     Document Type: Article

References (40)

1. Mori K, Watanabe H, Hiwatashi N, Sugai K, Goto Y. Studies on blood coagulation in ulcerative colitis and Crohn's disease. Tohoku J Exp Med 1980;132:93-101.
2. Gallmetzer P, Leutmezer F, Serles W, Assem-Hilger E, Spatt J, Baumgartner C. Postictal paresis in focal epilepsies: incidence, duration, and causes: a video-EEG monitoring study. Neurology 2004;62:2160-2164.
3. Kimura M, Sejima H, Ozasa H, Yamaguchi S. Technetium-99m-HMPAO SPECT in patients with hemiconvulsions followed by Todd's paralysis. Pediatr Ra-diol 1998;28:92-94.
4. Giroud M, Lemesle M, Madinier G, Manceau E, Osseby GV, Dumas R. Stroke in children under 16 years of age: clinical and etiological difference with adults. Acta Neurol Scand 1997;96:401-406.
5. Selekler HM, Erdogan MS, Budak F. Prevalence and clinical characteristics of an experimental model of'ice-cream headache' in migraine and episodic tension-type headache patients. Cephalalgia 2004;24:293-297.
6. Al-Twaijri WA, Shevell MI. Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr Neurol 2002;26:365-368.
7. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12:221-228; discussion 186.
8. Lewis DW. Pediatric migraine. Neurol Clin 2009;27:481-501.
9. Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain 1994;117:199-210.
10. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24(SUPPL. 1):9-160.
11. Lance JW, Goadsby PJ. Mechanism and Management of Headache, 6th ed. Boston: Butterworth Heinemann; 1998.
12. Foroozan R, Cutrer FM. Transient neurologic dysfunction in migraine. Neurol Clin 2009;27:361-378.
13. Young W, Silberstein S. Migraine: spectrum of symptoms and diagnosis. Continuum Headache 2006;12:67-86.
14. Jackson JH. Notes on the physiology and pathology of the nervous system. Med Times Gaz 1868;ii:696.
15. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(SUPPL. 7):1-96.
16. Evans RW, Lipton RB. Topics in migraine management: a survey of headache specialists highlights some controversies. Neurol Clin 2001;19:1-21.
17. Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010;74:628-635.
18. Kurth T. Migraine and ischaemic vascular events. Cephalalgia 2007;27:965-975.
19. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005;64:1020-1026. (Pubitemid 40388455)
20. Goadsby PJ. Hemiplegic migraine-a cerebral ionopathy. In: Squire LR, ed. New Encyclopedia of Neuroscience. Oxford: Academic Press; 2009:1073-1080.
21. Thomsen LL, Ostergaard E, Romer SF, et al. Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia 2003;23:921-928. (Pubitemid 37352630)
22. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-552.
23. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005;366:371-377.
24. De Fusco M, Marconi R, Silvestri L, et al. Haploinsuffi-ciency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003;33:192-196.
25. Thomsen LL, Kirchmann M, Bjornsson A, et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain 2007;130:346-356.
26. Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003;60:595-601.
27. Bhatia R, Desai S, Tripathi M, et al. Sporadic hemiplegic migraine: report of a case with clinical and radiological features. J Headache Pain 2008;9:385-388.
28. Van Den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004;41:701-710.
29. Klapper J, Mathew N, Nett R. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 2001;41:981-984.
30. Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol 2002;44: 490-493.
31. Rosman NP, Douglass LM, Sharif UM, Paolini J. The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature. J Child Neurol 2009;24:155-160.
32. Shevell MI. Familial acephalgic migraines. Neurology 1997;48:776-777.
33. Khatri R, Hershey AD, Wong B. Prochlorperazine-treat-ment for acute confusional migraine. Headache 2009;49: 477-480.
34. Wheeler SD. Phenotype-driven preventive strategies for migraine and other headaches. Neurologist 2009;15: 59-70.
35. Basheer A, Goadsby PJ, Prabhakar P. Flunarizine for pae-diatric headache: a ten year review. Cephalalgia (in press 2010).
36. Yu W, Horowitz SH. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 2003;60:120-121.
37. Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997;48:261-262.
38. Kaube H, Herzog J, Kaufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000; 55:139-141.
39. Andreou AP, Goadsby PJ. Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opin Investig Drugs 2009;18:789-803.
40. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishka-nian G, Lewis DW. Efficacy and tolerability of al-motriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008;48:1326-1336.